Previous research in cardiovascular disease has shown that active VD metabolic pathways regulate endothelial nitric oxide synthase expression or activity through transcriptome or epigenetic pathways, thereby mitigating inflammatory vascular endothelial cell damage or dysfunction [33]. The gene discussed is NOS3; the disease is cardiovascular disorder.